The impact of pre-hospital thrombolytic treatment on re-infarction rates: Analysis of the Myocardial Infarction National Audit project (MINAP) Dr Simon.

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

GUSTO-IV AMI G lobal U se of S trategies T o Open O ccluded Coronary Arteries in AMI.
Local improvement following national clinical audit workshops Auditing heart attacks Saving lives Dr Andrew Wragg Barts Health.
Better or bigger: How should we organise emergency care Jon Nicholl School of Health and Related Research University of Sheffield England.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
The Influence of Radial vs. Femoral Access on Acute Blood Loss in Patients Undergoing Percutaneous Coronary Intervention Amit Nanda 1, Eric Novak MS 2,
The Influence of Radial vs. Femoral Access on Acute Blood Loss in Patients Undergoing Percutaneous Coronary Intervention Amit Nanda 1, Amit P. Amin 2,
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
Minimising Critical Incidents in Myocardial Infarction in the Emergency Department Dr John Ryan.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Authors: Somkereki Cristina, Dr. Hadadi L.
Prehospital Fibrinolysis with Double Antiplatelet Therapy in Acute ST-Elevation Myocardial Infarction: The Clarity Ambulance Substudy Prehospital Fibrinolysis.
Journal Club By Ben Selph, Mercer COPHS April 6, 2012 SEGA Geriatrics.
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Quality Improvement Initiatives. National Service Framework for Coronary Heart Disease-UK Cooperative Cardiovascular Project (CCP)-USA National Registry.
Primary Care Acute Chest Pain Awareness. Background BHF Funded Mid & South West Wales Project –Report from MINAP (Myocardial Ischaemia National Audit.
Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.
Chicago 2014 TFQO: Darren Walters COI #317 EVREV 1: Darren Walters COI #317 EVREV 2: Chris Ghaemmaghami COI #60 Taskforce: Acute Coronary Syndrome In STEMI.
Acute Myocardial Infarction Joseph D. Lynch, MD. Acute Myocardial Infarction Mechanism Clinical Presentation Diagnosis Management.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST- ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA - II SUBSTUDY.
Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 Bimal R. Shah,
1 Statistical Review of the Observational Studies of Aprotinin Safety Part II: The i3 Drug Safety Study CRDAC and DSaRM Meeting September 12, 2007 P. Chris.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
Acute Myocardial Infarction February 8, 2006.
Dallas 2015 TFQO: Hiroshi Nonogi #254 EVREVs: Hiroshi Nonogi #254 Tony Scott #138 Taskforce: ACS Fibrinolytic and immediate PCI for STEMI 882.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Pre-hospital Thrombolysis A View from the Front Line Lancashire Ambulance Service NHS Trust Paul Bastow MA SRPara Clinical Effectiveness Manager.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Depression As a Predictor of Mortality and Hospitalization Among Hemodialysis Patients in the United States and Europe.
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
A Clinical profile of patients enrolled in the Pakistan ACS registry
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Management of ST-Elevation Myocardial Infarction
Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study Nilsson G1,
Heart Disease in the Acute Hospital
Use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study Gunnar.
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
European Heart Association Journal 2007 April
Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.
Date: Presenter: Ryan Chen
Risk adjustment using administrative and clinical data: model comparison
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Impact of Platelet Reactivity Following Clopidogrel Administration
American College of Cardiology Presented by Dr. Michel R. Le May
Global Registry of Acute Coronary Events: GRACE
Primary Care Acute Chest Pain Awareness Project
Nat. Rev. Cardiol. doi: /nrcardio
National Quality Assessment of Early Clopidogrel Therapy in Chinese Patients With Acute Myocardial Infarction (AMI) in 2006 and 2011: Insights From the.
Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study Shi Zhao, Karthik.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
The various causes of electrocardiographic ST segment depression.
Trends in Early Aspirin Use Among Patients With Acute Myocardial Infarction in China, 2001–2011: The China PEACE-Retrospective AMI Study Yan Gao, Frederick.
(Case 1) ST segment depression attributable to myocardial ischaemia (non-infarction)—ECG demonstrated NSR with ST segment depression in the anterolateral.
(Case 2) Reciprocal ST segment depression—the ECG demonstrated early anterolateral AMI with reciprocal ST segment depression in the inferior leads. (Case.
Non-ST segment elevation AMI—AMI characteristically presents with STE in approximately 50% of myocardial infarction patients; in the remainder of the AMI.
(Case 3) Acute, isolated posterior wall myocardial infarction.
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Presentation transcript:

The impact of pre-hospital thrombolytic treatment on re-infarction rates: Analysis of the Myocardial Infarction National Audit project (MINAP) Dr Simon Horne Specialist Registrar Emergency Medicine Torbay Hospital

Background to the study Pre-hospital thrombolysis allows earlier treatment of Acute Myocardial Infarction (AMI). This in turn improves outcome. Ambulance systems allow real time observation of the pre-hospital ECG in the Emergency department. Anecdotal evidence suggested a high rate of re- infarction after pre-hospital treatment.

What is re-infarction? “Ischaemic pain or other symptoms consistent with acute cardiac ischaemia …accompanied by new electrocardiographic changes (elevation or depression of the ST segment or T waves changes) in the territory of the initial event”

Why re-infarction is important

Study hypothesis That pre-hospital thrombolysis has a higher rate of re-infarction than in-hospital thrombolysis.

Methods Use of the MINAP database of 35,356 patients thrombolysed in Comparison of pre-hospital and in-hospital groups to identify differences in baseline characteristics and re-infarction rate. Use of multivariate linear regression to identify factors predictive of re-infarction.

Baseline characteristics

Re-infarction rate by agent * * * p=0.001 † † † p=0.005

Re-infarction rate by time from administration to time of arrival at hospital † † † p=0.001

Predictors of re-infarction For Tenecteplase: Weight OR 1.67 (95%CI ) Pre-hospital OR 1.44 (95%CI ) Previous AMIOR 1.23 (95%CI ) For Reteplase: Previous AMIOR 2.74 (95%CI ) CRFOR 2.6 (95%CI )

Why might this happen? Chance? A difference between the groups that we have no data about? Anticoagulation?

Limitations of the study Use of a dataset for a specific question for which it was not designed. No randomisation to reduce bias. Data quality is an issue. No direct evidence of cause, only effect. but Complete picture for England and Wales. Robust evidence that something about pre- hospital thrombolysis is suboptimal.

Conclusions Pre-hospital thrombolysis with Tenecteplase is associated with an increased risk of re- infarction. Re-infarction more than doubles mortality from AMI. As time from treatment to hospital increases, so does the rate of re-infarction. The anticoagulation regimen is an obvious difference between the groups that might explain the results.